Blog

Zepbound is FDA-approved for moderate to severe obstructive sleep apnea in adults with obesity, and Wegovy has data and growing clinical interest in the same space. That opens a new DTC telehealth program category. Sleep apnea care is not just weight loss care with a sleep score attached. It needs its own intake, home sleep testing workflow, CPAP coordination, and provider review.

New GLP-1 products in 2026 are changing the operating model for telehealth teams. Oral GLP-1s, higher-dose semaglutide, direct-access channels, pipeline combination therapies, and tighter compounding scrutiny all require clearer intake, billing, pharmacy, and patient education workflows.

Patients are searching for peptides for weight loss, but the category mixes FDA-approved GLP-1 medications, compounded GLP-1 products, investigational peptides, and wellness claims. DTC telehealth teams need clear intake, compliant marketing, provider review, pharmacy safeguards, and patient education before building around the trend.

GLP-1 microdosing is getting patient attention, but it is not a standardized or FDA-approved dosing strategy. Telehealth teams need clear intake, provider review, support scripts, and safety boundaries before patients start asking about it.

The GLP-1 category is splitting into oral, injectable, combination, dual-agonist, and triple-agonist pathways. Here is the May 2026 approval watchlist and what telehealth teams should prepare operationally.

Cash-pay GLP-1 patients are no longer comparing only telehealth brands. They are comparing manufacturer-direct programs, retail pharmacy access, local pickup, delivery, subscription models, provider review, and the support experience after payment.

The FDA's March 2026 warning letters to telehealth companies are not just a legal story. They are a product, advertising, landing-page, intake, and support-workflow story for every GLP-1 team still operating in a noisy market.

GLP-1 programs that stop at prescribing are easier to launch but harder to retain. Nutrition support helps patients manage side effects, protect muscle, stay confident through refills, and understand what the medication is supposed to fit inside.

As self-pay GLP-1 access expands beyond direct channels into major pharmacy pickup, telehealth teams need to rethink refill timing, billing clarity, patient communication, and post-prescription visibility.

Running GLP-1 ads in 2026 takes more than good creative. Here is how telehealth teams should think about channel restrictions, compliance, funnel design, and what still converts.

Oral GLP-1s are no longer a future category. With Foundayo and the Wegovy pill now in the market, telehealth teams need to understand how pills change positioning, onboarding, adherence, and refill workflows.

In 2026, GLP-1 product strategy is moving beyond a simple semaglutide vs tirzepatide story. Oral launches, higher-dose SKUs, new indications, pricing moves, and tighter FDA scrutiny are reshaping the market.

Choosing a compounding pharmacy is an operations decision, not just a sourcing decision. Here is how telehealth teams evaluate quality, workflow fit, and patient experience before they commit.

GLP-1 refill operations break when timing, patient communication, and exception handling are disconnected. Here is a workflow that keeps cycles on track and support volume under control.

A practical GLP-1 prior authorization workflow for telehealth teams that want fewer denials, faster submissions, and less patient frustration between approval steps.

A practical email framework for month 2 in GLP-1 programs, designed to reduce drop-off by improving refill clarity, support confidence, and continuity.

A practical guide to deciding which GLP-1 upsells should live in the patient portal instead of Shopify checkout, so offers feel timely, relevant, and trustworthy.

A practical framework for segmenting GLP-1 upsells by patient stage in Shopify so offers increase relevance without lowering trust or qualification quality.

A practical integration model for connecting Shopify-style e-commerce systems with GLP-1 intake, clinical review, fulfillment, and retention workflows.

A practical framework for deciding which GLP-1 upsells and add-ons belong in checkout, and which ones quietly damage trust, conversion quality, and retention.